Editorial: Deep Brain Stimulation Think Tank: Updates in Neurotechnology and Neuromodulation, Volume II

Related Articles:

• Editorial: Deep Brain Stimulation Think Tank: Updates in Neurotechnology and Neuromodulation, Volume II June 20, 2022 Front Hum Neurosci. 2022 Jun 1;16:912730. doi: 10.3389/fnhum.2022.912730. eCollection 2022.NO ABSTRACTPMID:35721359 | PMC:PMC9198546 | DOI:10.3389/fnhum.2022.912730
• Editorial: Deep Brain Stimulation Think Tank: Updates in Neurotechnology and Neuromodulation, Volume II June 20, 2022 Front Hum Neurosci. 2022 Jun 1;16:912730. doi: 10.3389/fnhum.2022.912730. eCollection 2022.NO ABSTRACTPMID:35721359 | PMC:PMC9198546 | DOI:10.3389/fnhum.2022.912730
• Editorial: Deep Brain Stimulation Think Tank: Updates in Neurotechnology and Neuromodulation, Volume II June 20, 2022 Front Hum Neurosci. 2022 Jun 1;16:912730. doi: 10.3389/fnhum.2022.912730. eCollection 2022.NO ABSTRACTPMID:35721359 | PMC:PMC9198546 | DOI:10.3389/fnhum.2022.912730
• DBS: location, location, location December 15, 2019   Deep brain stimulation (or DBS) represents a well established treatment option for individuals with Parkinson’s who no longer respond to standard therapies. It involves tiny electrodes being embedded in the brain and they modulate populations of neurons that have become dysfunctional. The results of the DBS procedure can be “miraculous” for some individuals – reducing tremors and significantly improving…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Deep Brain Stimulation for Parkinson’s - An Update February 1, 2019 (Guest post by Dr. Eric Rhoden, PT, DPT)Until recently deep brain stimulation (DBS) for Parkinson’s Disease has been a monopolized industry run and operated by Medtronic, who has produced an amazing device that has changed countless lives. However, technology has developed at a rapid pace over the last year, and now there are more options to be aware of when…
• Mind blowing modulation of mind October 12, 2021 # # # # Neuromodulation of specific circuits in the brain represents a means of adjusting deficits in neural performance and significantly improving quality of life. Deep brain stimulation has been widely applied to the treatment of Parkinson’s since Alim Benabid first discovered that electrical stimulation of the basal ganglia improves the symptoms of the condition in the late 1980s.…
• Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and Optogenetics. October 2, 2019 Proceedings of the Sixth Deep Brain Stimulation Think Tank Modulation of Brain Networks and Application of Advanced Neuroimaging, Neurophysiology, and Optogenetics. Front Neurosci. 2019;13:936 Authors: Ramirez-Zamora A, Giordano J, Boyden ES, Gradinaru V, Gunduz A, Starr PA, Sheth SA, McIntyre CC, Fox MD, Vitek J, Vedam-Mai V, Akbar U, Almeida L, Bronte-Stewart HM, Mayberg HS, Pouratian N, Gittis AH, Singer…
• The road ahead: 2022 January 20, 2022 # # # # The first post at the start of each year on the SoPD website tries to provide an overview of where things are in the search for ‘disease modifying’ therapies for Parkinson’s.  It is an exercise in managing expectations as well as discussing what research events are scheduled for the next year so that we can keep…
• Monthly Research Review – December 2020 December 31, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during December 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Conferences/lectures Other news…
• Abbott Partners with NIH on BRAIN Initiative to Use Neuromodulation Technologies May 16, 2019 Abbott is partnering with the National Institutes of Health (NIH) to explore the use of its neuromodulation technologies for treating chronic pain and progressive movement disorders, including Parkinson’s disease. The partnership’s goal is to drive forward the Brain Research through Advancing Innovative Neurotechnologies initiative, known as BRAIN, which is working to accelerate neuroscience research. With this collaboration agreement, Abbott will…
• Research Into Non-invasive Deep Brain Stimulation Earns Grossman Prize for Neuromodulation August 9, 2018 The 2018 Science & PINS Prize for Neuromodulation was awarded to Nir Grossman, PhD, for his research to stimulate deep and specific regions of the brain without surgery as a treatment for Parkinson’s disease and other disorders. Grossman, who is an assistant professor at Imperial College London and a fellow of the U.K. Dementia Research Institute, will receive $25,000 and…
• Deep Brain Stimulation: The Answer to Chronic Pain? January 15, 2021 Chronic pain affects 1 in every 4 adults in the United States, many of whom are resistant to pharmacotherapy.1 It is a significant burden to both individuals and healthcare systems, affecting mental health, cognitive function, and promoting opioid dependency.2 However, researchers are hot on the heels of discovering new ways to treat the condition — including via deep brain stimulation…
• Monthly research review: February 2020 February 29, 2020   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during February 2020. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• Monthly Research Review – September 2019 September 30, 2019   At the end of each month the SoPD writes a post which provides an overview of some of the major pieces of Parkinson’s-related research that were made available during September 2019. The post is divided into seven parts based on the type of research: Basic biology Disease mechanism Clinical research New clinical trials Clinical trial news Other news Review…
• The Unreasonable Effectiveness of Deep Brain Stimulation Therapy and the Future of Neuromodulation September 25, 2021 When DBS electrodes are properly placed the results are nothing short of a modern medical miracle. However, in most patients the effectiveness wanes over time. There are a lot of theories as to why, below I will try to explain the one that makes the most sense to me, sometimes referred to as the Habituation Model. (I am going to…
• 2019: Year in review December 31, 2019   In this end-of-year post, we review the Parkinson’s research that caught our attention at SoPD HQ in 2019. Month-by-month we will briefly discuss some of the major pieces of research/announcements that have defined the year and advanced our understanding of Parkinson’s. The list is based on nothing more than the author’s personal opinion – apologies to any researchers who…
• The road ahead: 2021 January 25, 2021 # # # # At the start of each year, it is a useful practise to layout what is planned over the next 12 months. The events that are scheduled for the year to come, so that we can keep an eye out for them. Obviously, where 2021 will end actually is unpredictable, but an outline of what is scheduled…
• The road ahead: 2020 January 5, 2020 Here at the SoPD, we are primarily interested in disease modification for Parkinson’s. While there is a great deal of interesting research exploring the causes of the condition, novel symptomatic therapies, and other aspects of Parkinson’s, my focus is generally on the science seeking to slow, stop or reverse the condition. At the start of each year, it is a…